Solid Team:Lynne Sullivan, Chief Financial Officer at Unity Biotechnology

Board Sullivan

Ms. Sullivan is a member of the board of directors for Solid Biosciences.

Lynne Sullivan has served as a member of our board of directors since November 2015. Ms. Sullivan is currently the Chief Financial Officer of UNITY Biotechnology, Inc. She previously served as the Chief Financial Officer for Compass Therapeutics, LLC, a biotechnology company, from December 2018 to August 2019. Prior to Compass, Ms. Sullivan was Biogen’s Senior Vice President of Finance from 2016 to December 2018, where she also served as Vice President of Tax and Corporate Finance from February 2015 to March 2016 and Vice President of Tax from April 2008 to February 2015. She is currently a member of the board of directors of resTORbio, Inc. and BiomX Inc. both of which are public biopharmaceutical companies. Ms. Sullivan also serves on the board of Inheris Biopharma, Inc., a private biopharmaceutical company. She received an M.S. in Taxation from Bentley University and a B.S.B.A. from Suffolk University. Ms. Sullivan was a Certified Public Account for over 20 years.